BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 9140287)

  • 1. Use of myeloperoxidase mRNA as a marker for myeloid lineage in acute leukemias.
    Crisan D; David D; DiCarlo R
    Arch Pathol Lab Med; 1996 Sep; 120(9):828-34. PubMed ID: 9140287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of Myeloperoxidase mRNA in Monitoring Patients With Acute Myelogenous Leukemia for Early Detection of Circulating Blasts.
    Crisan D; David D
    Mol Diagn; 1996 Dec; 1(4):313-319. PubMed ID: 10462578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of leukemic blasts in peripheral blood specimens by reverse transcriptase polymerase chain reaction assay for myeloperoxidase mRNA.
    Zhang W; Austin GE; Farhi DC; Zaki SR
    Diagn Mol Pathol; 1993 Dec; 2(4):283-9. PubMed ID: 8118606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular diagnostic testing for determination of myeloid lineage in acute leukemias.
    Crisan D
    Ann Clin Lab Sci; 1994; 24(4):355-63. PubMed ID: 7944272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new procedure for cell lineage determination in acute leukemias. Myeloperoxidase mRNA detection.
    Crisan D; Kaplan SS; Penchansky L; Krause JR
    Diagn Mol Pathol; 1993 Jun; 2(2):65-73. PubMed ID: 8269279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myeloperoxidase mRNA detection for lineage determination of leukemic blasts: retrospective analysis.
    Crisan D; Anstett MJ
    Leukemia; 1995 Jul; 9(7):1264-75. PubMed ID: 7630202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myeloperoxidase cytochemical negativity: an unexpected but intrinsic property of blasts of all phases of chronic myeloid leukemia.
    Anand M; Ghara N; Kumar R; Singh S; Sengar M; Panikar N; Raina V; Sharma A
    Ann Hematol; 2005 Nov; 84(12):767-70. PubMed ID: 15990995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myeloperoxidase mRNA analysis in acute lymphoblastic leukemia.
    Crisan D; Topalovski M; O'Malley B
    Diagn Mol Pathol; 1996 Dec; 5(4):236-48. PubMed ID: 8955614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of myeloperoxidase activity in primary leukemic cells by an enhanced chemiluminescent assay for differentiation between acute lymphoblastic and non-lymphoblastic leukemia.
    Tan S; Wang G; Peng M; Zhang X; Shen G; Jiang J; Chen F
    Clin Chim Acta; 2009 May; 403(1-2):216-8. PubMed ID: 19298796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cytomorphology of acute mixed leukemia].
    Sucić M; Batinić D; Zadro R; Mrsić S; Labar B
    Acta Med Croatica; 2008 Oct; 62(4):379-85. PubMed ID: 19205415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of myeloperoxidase mRNA by leukemic cells from childhood acute lymphoblastic leukemia.
    Zhou M; Findley HW; Zaki SR; Little F; Coffield LM; Ragab AH
    Leukemia; 1993 Aug; 7(8):1180-3. PubMed ID: 8394481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The ultrastructure of hybrid acute leukemia: a study of 15 cases.
    Ru YX; Wang HJ; Yang BX; Liu JH; Li ZQ; Li CW; Wang JX; Mi YC
    Ultrastruct Pathol; 2005; 29(5):341-7. PubMed ID: 16257860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myeloperoxidase gene expression in acute leukemias.
    Morishita Y; Yano K
    Nihon Ketsueki Gakkai Zasshi; 1989 Dec; 52(8):1459-62. PubMed ID: 2560887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone marrow biopsy imprint preparations: use for molecular diagnostics in leukemias.
    Crisan D; Farkas DH
    Ann Clin Lab Sci; 1993; 23(6):407-22. PubMed ID: 8291896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative analysis of different permeabilization methods for the flow cytometry measurement of cytoplasmic myeloperoxidase and lysozyme in normal and leukemic cells.
    Lanza F; Latorraca A; Moretti S; Castagnari B; Ferrari L; Castoldi G
    Cytometry; 1997 Jun; 30(3):134-44. PubMed ID: 9222099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The immunophenotype of blast transformation of chronic myelogenous leukemia: a high frequency of mixed lineage phenotype in "lymphoid" blasts and A comparison of morphologic, immunophenotypic, and molecular findings.
    Khalidi HS; Brynes RK; Medeiros LJ; Chang KL; Slovak ML; Snyder DS; Arber DA
    Mod Pathol; 1998 Dec; 11(12):1211-21. PubMed ID: 9872654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Terminal deoxynucleotidyl transferase in various immunophenotypic cells in leukemia].
    Tang YM
    Zhonghua Yi Xue Za Zhi; 1992 Sep; 72(9):544-6, 573-4. PubMed ID: 1338518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunophenotyping of acute leukemias: diagnostic and pronostic utility in Abidjan, Côte d'Ivoire].
    Inwoley KA; Sawadogo D; Mizero L; Salou M; Karim N; Sangaré A
    Bull Soc Pathol Exot; 2004; 97(5):319-22. PubMed ID: 15787262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leukemia markers expression of peripheral blood vs bone marrow blasts using flow cytometry.
    Rezaei A; Adib M; Mokarian F; Tebianian M; Nassiri R
    Med Sci Monit; 2003 Aug; 9(8):CR359-62. PubMed ID: 12942032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytochemically myeloperoxidase positive childhood acute leukemia with lymphoblastic morphology treated as lymphoblastic leukemia.
    Steiner M; Attarbaschi A; Dworzak M; Strobl H; Pickl W; Kornmüller R; Haas O; Gadner H; Mann G;
    J Pediatr Hematol Oncol; 2010 Jan; 32(1):e4-7. PubMed ID: 19935430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.